Neville Heather L, Mann Kelsey, Killen Jessica, Callaghan Michael
, BScPharm, MSc, FCSHP, is with Nova Scotia Health, Halifax, Nova Scotia.
, BScPharm, was, at the time of this study, with Nova Scotia Health, Halifax, Nova Scotia.
Can J Hosp Pharm. 2021 Fall;74(4):350-360. doi: 10.4212/cjhp.v74i4.3198.
Despite ample evidence of benefit, adherence to secondary prevention medication therapy after acute coronary syndrome (ACS) is often suboptimal. Hospital pharmacists are uniquely positioned to improve adherence by providing medication education at discharge.
To determine whether a standardized counselling intervention at hospital discharge significantly improved patients' adherence to cardiovascular medications following ACS.
This single-centre, prospective, nonrandomized comparative study enrolled patients with a primary diagnosis of ACS (January 2014 to July 2015). Patients who received standardized discharge counselling from a clinical pharmacist were compared with patients who did not receive counselling. At 30 days and 1 year after discharge, follow-up patient surveys were conducted and community pharmacy refill data were obtained. Adherence was assessed using pharmacy refill data and patient self-reporting for 5 targeted medications: acetylsalicylic acid, P2Y purinoceptor 12 (P2Y12) inhibitors, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, β-blockers, and statins. Thirty-day and 1-year medication utilization, cardiovascular readmission rates, and all-cause mortality were also assessed.
Of the 259 patients enrolled, 88 (34.0%) received discharge counselling. Medication data were obtained for 253 patients (97.7%) at 30 days and 242 patients (93.4%) at 1 year. At 1 year after discharge, there were no statistically significant differences between patients who did and did not receive counselling in terms of rates of nonadherence (11.9% versus 18.4%, = 0.19), cardiovascular readmission (17.6% versus 22.3%, = 0.42), and all-cause mortality (3.4% versus 4.2%, > 0.99). Overall medication nonadherence was 2.8% (7/253) at 30 days and 16.1% (39/242) at 1 year.
Discharge medication counselling provided by hospital pharmacists after ACS was not associated with significantly better medication adherence at 1 year. Higher-quality evidence is needed to determine the most effective and practical interventions to ensure that patients adhere to their medication regimens and achieve positive outcomes after ACS.
尽管有充分证据表明二级预防药物治疗有益,但急性冠状动脉综合征(ACS)后患者对二级预防药物治疗的依从性往往不理想。医院药剂师在出院时提供药物教育,在改善依从性方面具有独特优势。
确定出院时的标准化咨询干预是否能显著提高ACS患者对心血管药物的依从性。
这项单中心、前瞻性、非随机对照研究纳入了初步诊断为ACS的患者(2014年1月至2015年7月)。将接受临床药剂师标准化出院咨询的患者与未接受咨询的患者进行比较。在出院后30天和1年时,进行随访患者调查并获取社区药房的配药数据。使用药房配药数据和患者自我报告对5种目标药物的依从性进行评估:乙酰水杨酸、P2Y嘌呤受体12(P2Y12)抑制剂、血管紧张素转换酶抑制剂或血管紧张素II受体阻滞剂、β受体阻滞剂和他汀类药物。还评估了30天和1年时的药物使用情况、心血管疾病再入院率和全因死亡率。
在纳入的259例患者中,88例(34.0%)接受了出院咨询。30天时获取了253例患者(97.7%)的用药数据,1年时获取了242例患者(93.4%)的用药数据。出院1年后,接受咨询和未接受咨询的患者在不依从率(11.9%对18.4%,P = 0.19)、心血管疾病再入院率(17.6%对22.3%,P = 0.42)和全因死亡率(3.4%对4.2%,P>0.99)方面无统计学显著差异。总体药物不依从率在30天时为2.8%(7/253),1年时为16.1%(39/242)。
ACS后医院药剂师提供的出院药物咨询在1年时与显著更好的药物依从性无关。需要更高质量的证据来确定最有效和实用的干预措施,以确保患者坚持药物治疗方案并在ACS后取得积极结果。